Your browser doesn't support javascript.
loading
MAPK7 Regulates EMT Features and Modulates the Generation of CTCs.
Javaid, Sarah; Zhang, Jianmin; Smolen, Gromoslaw A; Yu, Min; Wittner, Ben S; Singh, Anurag; Arora, Kshitij S; Madden, Marissa W; Desai, Rushil; Zubrowski, Matthew J; Schott, Benjamin J; Ting, David T; Stott, Shannon L; Toner, Mehmet; Maheswaran, Shyamala; Shioda, Toshi; Ramaswamy, Sridhar; Haber, Daniel A.
Affiliation
  • Javaid S; Massachusetts General Hospital Cancer Center and Harvard Medical School, Charlestown, Massachusetts. Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Charlestown, Massachusetts.
  • Zhang J; Massachusetts General Hospital Cancer Center and Harvard Medical School, Charlestown, Massachusetts.
  • Smolen GA; Massachusetts General Hospital Cancer Center and Harvard Medical School, Charlestown, Massachusetts.
  • Yu M; Massachusetts General Hospital Cancer Center and Harvard Medical School, Charlestown, Massachusetts.
  • Wittner BS; Massachusetts General Hospital Cancer Center and Harvard Medical School, Charlestown, Massachusetts. Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Charlestown, Massachusetts.
  • Singh A; Massachusetts General Hospital Cancer Center and Harvard Medical School, Charlestown, Massachusetts.
  • Arora KS; Massachusetts General Hospital Cancer Center and Harvard Medical School, Charlestown, Massachusetts.
  • Madden MW; Massachusetts General Hospital Cancer Center and Harvard Medical School, Charlestown, Massachusetts.
  • Desai R; Massachusetts General Hospital Cancer Center and Harvard Medical School, Charlestown, Massachusetts.
  • Zubrowski MJ; Massachusetts General Hospital Cancer Center and Harvard Medical School, Charlestown, Massachusetts.
  • Schott BJ; Massachusetts General Hospital Cancer Center and Harvard Medical School, Charlestown, Massachusetts.
  • Ting DT; Massachusetts General Hospital Cancer Center and Harvard Medical School, Charlestown, Massachusetts. Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Charlestown, Massachusetts.
  • Stott SL; Massachusetts General Hospital Cancer Center and Harvard Medical School, Charlestown, Massachusetts. Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Charlestown, Massachusetts. BioMEMS Resource Center, Massachusetts General Hospital Center for Bioengineering in Med
  • Toner M; BioMEMS Resource Center, Massachusetts General Hospital Center for Bioengineering in Medicine, Charlestown, Massachusetts. Department of Surgery, Massachusetts General Hospital and Harvard Medical School, Charlestown, Massachusetts.
  • Maheswaran S; Massachusetts General Hospital Cancer Center and Harvard Medical School, Charlestown, Massachusetts. Department of Surgery, Massachusetts General Hospital and Harvard Medical School, Charlestown, Massachusetts.
  • Shioda T; Massachusetts General Hospital Cancer Center and Harvard Medical School, Charlestown, Massachusetts. Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Charlestown, Massachusetts.
  • Ramaswamy S; Massachusetts General Hospital Cancer Center and Harvard Medical School, Charlestown, Massachusetts. Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Charlestown, Massachusetts.
  • Haber DA; Massachusetts General Hospital Cancer Center and Harvard Medical School, Charlestown, Massachusetts. Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Charlestown, Massachusetts. Howard Hughes Medical Institute, Chevy Chase, Maryland. haber@helix.mgh.harvard.edu.
Mol Cancer Res ; 13(5): 934-43, 2015 May.
Article in En | MEDLINE | ID: mdl-25678598
UNLABELLED: Epithelial-to-mesenchymal transition (EMT) has been implicated in models of tumor cell migration, invasion, and metastasis. In a search for candidate therapeutic targets to reverse this process, nontumorigenic MCF10A breast epithelial cells were infected with an arrayed lentiviral kinome shRNA library and screened for either suppression or enhancement of a 26-gene EMT RNA signature. No individual kinase gene knockdown was sufficient to induce EMT. In contrast, grouped epithelial markers were induced by knockdown of multiple kinases, including mitogen activated protein kinase 7 (MAPK7). In breast cancer cells, suppression of MAPK7 increased E-cadherin (CDH1) expression and inhibited cell migration. In an orthotopic mouse model, MAPK7 suppression reduced the generation of circulating tumor cells and the appearance of lung metastases. Together, these observations raise the possibility that targeting kinases that maintain mesenchymal cell properties in cancer cells, such as MAPK7, may lessen tumor invasiveness. IMPLICATIONS: Suppression of MAPK7 induces epithelial markers, reduces generation of circulating tumor cells and appearance of lung metastases.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Mitogen-Activated Protein Kinase 7 / Neoplastic Cells, Circulating Limits: Animals / Female / Humans Language: En Journal: Mol Cancer Res Journal subject: BIOLOGIA MOLECULAR / NEOPLASIAS Year: 2015 Document type: Article Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Mitogen-Activated Protein Kinase 7 / Neoplastic Cells, Circulating Limits: Animals / Female / Humans Language: En Journal: Mol Cancer Res Journal subject: BIOLOGIA MOLECULAR / NEOPLASIAS Year: 2015 Document type: Article Country of publication: United States